Delayed onset serotonin syndrome in the setting of polypharmacy
Serotonin syndrome is a rare but well-known condition that can be life-threatening if not diagnosed early. Onset is usually within 4 to 13 h of starting the offending medication. We present a case of delayed onset of serotonin syndrome that presented after 48 h. Polypharmacy played a role in causing...
Main Authors: | Roshan Acharya, Smita Kafle, Sijan Basnet, DilliRam Poudel, Sushil Ghimire |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | Journal of Community Hospital Internal Medicine Perspectives |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/20009666.2020.1834929 |
Similar Items
-
The Serotonin Syndrome: From Molecular Mechanisms to Clinical Practice
by: James Francescangeli, et al.
Published: (2019-05-01) -
POLYPHARMACY: RESPONSE
by: S. O. Kluchnikov
Published: (2015-08-01) -
Polypharmacy and Postoperative Delirium in Urology
by: Yu Seob Shin, et al.
Published: (2020-05-01) -
Polypharmacy in the elderly
by: Negar Golchin, et al.
Published: (2015-01-01) -
Pharmacotherapy of Schizophrenia: Ploypharmacy Approaches
by: Fatemeh Rahiminejad, et al.
Published: (2010-07-01)